Herbal and dietary supplements can adversely affect prescribed drugs says extensive review

October 24, 2012 in Medications

A number of herbs and dietary supplements (HDS) can cause potentially harmful drug interactions, particularly among people receiving medication for problems with their central nervous or cardiovascular systems.

Those are the key findings of an extensive research review published in the November issue of IJCP, the .

Researchers examined 54 review articles and 31 original studies. They found that the greatest problems were caused by interactions between prescribed drugs and HDS that included ingredients such as St John's Wort, magnesium, calcium, iron or ginkgo.

"Consumer use of HDS has risen dramatically over the past two decades" says co-author Dr Hsiang-Wen Lin from the College of Pharmacy, China Medical School, Taiwan.

"In the USA, for example, it is estimated that more than 50 per cent of patients with or cancer use them and that many patients take them at the same time as prescribed medication.

"Despite their widespread use, the potential risks associated with combining HDS with other medications, which include mild-to-severe , chest pain, abdominal pain and headache, are poorly understood."

Key findings of the review included:

  • The literature covered 213 HDS entities and 509 , with 882 HDS-drug interactions described in terms of their mechanisms and severity.
  • Warfarin, insulin, aspirin digoxin and ticlopidine had the greatest number of reported interactions with HDS.
  • More than 42 per cent of the drug interactions were caused by the HDS altering the pharmacokinetics of the prescribed drugs - the process by which a drug is absorbed, distributed, metabolised and eliminated by the body.
  • Just over 26 per cent of the total were described as major interactions.
  • Among the 152 identified contraindications, the most frequent involved the (16.4%), neurological system (14.5%) and andrenal ⁄ genitourinary diseases (12.5%).
  • , echinacea and yohimbe had the largest number of documented contraindications.

"Our extensive review clearly shows that some HDS ingredients have potentially harmful drug interactions that are predominately moderate in their severity" says Dr Lin. "It also showed that herbal and botanical remedies were more likely to have documented drug interactions and contraindications than the other dietary supplements, such as vitamins, minerals and amino acids."

In an editorial on the review, Professor Edzard Ernst, Emeritus Professor, University of Exeter says that the authors provide an impressively complete overview of a fascinating and potentially important subject.

"Survey after survey shows that large proportions of the population are trying 'natural' remedies for illness-prevention, all sorts of ailments, diseases or for states of reduced well-being" he says. "Most experts therefore agree that the potential for such interactions is substantial.

"Despite this consensus and despite the considerable amount of documented harm generated by such interactions, our current knowledge is still woefully incomplete."

Professor Ernst believes that the number of interactions between HDS and prescribed drugs could be under-reported and just the tip of the iceberg.

He feels that the situation calls for rigorous research, increased awareness of possible HDS prescription interactions by physicians and patients and greater government control of this public health issue.

"Patients deserve reliable information, and it is our duty to provide it" he says. "We have to become vigilant and finally agree to monitor this sector adequately. Each individual doctor can contribute to this process by routinely including questions about alternative medicine use in their medical history taking."

Journal reference: International Journal of Clinical Practice search and more info website

Provided by Wiley search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Merck ends development of Parkinson's disease drug

(AP)—Merck & Co. says it is ending development of an experimental Parkinson's disease drug because the drug wasn't working.

Medications created May 23, 2013 | popularity 1 / 5 (1) | comments 0

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

Medications created May 23, 2013 | popularity 5 / 5 (1) | comments 0

Experts favor US approval of Merck sleeping pill (Update)

An independent panel of experts on Wednesday recommended US approval of a new Merck sleeping pill called suvorexant, but expressed concerns over the highest dosage and risks of drowsy daytime driving.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Glaxo, US partnering to develop new antibiotics

GlaxoSmithKline PLC says it's starting an unusual collaboration with the U.S. government to develop several antibiotics for both bioterrorism threats and bacterial infections resistant to current medicines.

Medications created May 22, 2013 | popularity not rated yet | comments 0

Study finds new pneumococcal vaccine appears to be as safe as previously used vaccine

The new 13-valent pneumococcal conjugate vaccine (PCV13) appears to be as safe as the previous version used prior to 2010, the 7-valent pneumococcal conjugate vaccine (PCV7), according to a Kaiser Permanente study published ...

Medications created May 22, 2013 | popularity not rated yet | comments 0


Engineered cytomegalovirus protects monkeys from HIV equivalent

(Medical Xpress)—A new study by researchers in the US has shown that an ancient virus can be modified to help in the fight against the simian immunodeficiency virus SIV, which is the equivalent in monkeys ...

Researchers identify first drug targets in childhood genetic tumor disorder

Two mutations central to the development of infantile myofibromatosis (IM)—a disorder characterized by multiple tumors involving the skin, bone, and soft tissue—may provide new therapeutic targets, according to researchers ...

Hormone levels may provide key to understanding psychological disorders in women

Women at a particular stage in their monthly menstrual cycle may be more vulnerable to some of the psychological side-effects associated with stressful experiences, according to a study from UCL.

Going live: Immune cell activation in multiple sclerosis

Biological processes are generally based on events at the molecular and cellular level. To understand what happens in the course of infections, diseases or normal bodily functions, scientists would need to ...

Help at hand for people with schizophrenia

How can healthy people who hear voices help schizophrenics? Finding the answer for this is at the centre of research conducted at the University of Bergen.

Alzheimer's disease, the soft target of the euthanasia debate

(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.